ITHS Ignition Awards

The "Institute of Translational Health Sciences" (ITHS) was funded through the NIH Clinical and Translational Science Award (CTSA). The ITHS brings together scientists at the University of Washington, Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance (SCCA), Seattle Children's Hospital, Group Health Center for Health Studies, VA Puget Sound, Benaroya Research Institute Puget Sound Blood Center and other partner institutions in the Puget Sound region and in the WWAMI states to advance and transform clinical and translational research.
The purpose of the Ignition Awards is to support preclinical translational research in the areas of nonhuman primate models of human disease, drug delivery, transport, metabolism, pharmacokinetics, or pharmacogenetics and GMP manufacturing. This pilot funding should generate preliminary data to serve as a basis for submission of a new research grant application (e.g. R01-type grant to NIH or other funding agency) and/or subsequent clinical studies. Successful applicants are also provided preclinical development consulting through the Drug and Device Advisory Committee of the Institute of Translational Health Sciences.

Awards are selected on the basis of:
1. Applicability to the ITHS mission
2. Scientific merit
3. Proposed activities conducted on site at the WaNPRC
4. Innovation
5. Potential impact on human health
6. Potential for commercialization
7. Probability of future grant funding and/or clinical studies

Typical awards will be up to $50,000
For more information, please go to: http://www.iths.org/funding
Applications must be received by November 12, 2009